RESUMEN
OBJECTIVE: To clarify the epidemiologic characteristics and risk of other tumors in survivors of gynecological tumors. MATERIALS AND METHODS: This is a retrospective study based on the Surveillance, Epidemiology, and End Results database (SEER). RESULTS: The morbidity of other malignant tumors in patients with gynecological cancer was 8.07%. The most common subsequent tumors are breast, lung, colorectal, thyroid, and bladder cancers. Taking the incidence rate of the general population as reference, the second tumor with the highest relative risk in patients with cervical cancer is vulvar cancer. Bladder cancer is the second tumor with the highest relative risk value both in patients with corpus and ovarian cancer. The median period from the diagnosis of the initial tumor to the diagnosis of the second tumor was 5 years. Most patients with other tumors following gynecological cancer showed worse prognosis than patients with gynecological tumors only. However, thyroid cancer following ovarian cancer is a protective factor in survival. CONCLUSION: Patients with gynecological tumors have a significantly higher risk of malignant tumors in other systems compared to ordinary population. It is necessary to be vigilant against subsequent high-risk tumors and tumors with poor prognosis within 5 years of initial diagnosis.
RESUMEN
Tinea capitis is a common fungal infection in children, but it is rare in newborns. We report a case of a 3-week-old infant presenting with scalp annular erythema. She had a history of wearing a woolen hat one week before the disease onset. Wood's lamp and dermoscopic findings favoured the diagnosis of tinea capitis. Further examinations of her scalp, including direct KOH examination and fungal culture confirmed the diagnosis of tinea capitis caused by treatment with oral griseofulvin was effective. Neonatal tinea capitis is often misdiagnosed due to its rarity and atypical presentation. A thorough history (including the contacting history of clothes made of animal fur), physical examination and further mycological examinations are required for diagnosis. Griseofulvin, itraconazole and fluconazole have been reported to be effective drugs for the treatment of children tinea capitis. Liver enzymes should be regularly monitored during the period of using antifungal agents.
